273P A preoperative window-of-opportunity (WOO) study of imlunestrant in ER+, HER2- early breast cancer (EBC): Final analysis from EMBER-2
Year: 2023
Type: article
Source: Annals of Oncology
Authors: P. Neven, N. Stahl, M.J. Vidal Losada, M. Martin Jimenez, P.A. Kaufman, N. Harbeck, K. Hunt, S.A. Carter, F.C. Bidard, P. Fasching, P.G. Aftimos, D. Wheatley, E.P. Hamilton, R. Aft, S. Kulkarni, R. Ismail-Khan, C. Karacsonyi, S.T. Estrem, U. Ozbek, E.M. Ciruelos
Institutions: Universitair Ziekenhuis Leuven, Helios Hospital Schwerin, Hospital Clínic de Barcelona, Hospital General Universitario Gregorio Marañón, University of Vermont, Ludwig-Maximilians-Universität München, The University of Texas MD Anderson Cancer Center, Baylor College of Medicine, Institut Curie, Universitätsklinikum Erlangen, Institut Jules Bordet, Royal Cornwall Hospital, Sarah Cannon, Tennessee Oncology, Washington University in St. Louis, Alvin J. Siteman Cancer Center, Northwestern University, Eli Lilly (United States), Hospital Universitario 12 De Octubre
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4387808809